scispace - formally typeset
K

Kun-Der Lin

Researcher at Kaohsiung Medical University

Publications -  66
Citations -  1278

Kun-Der Lin is an academic researcher from Kaohsiung Medical University. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 20, co-authored 58 publications receiving 1007 citations. Previous affiliations of Kun-Der Lin include The Texas Heart Institute.

Papers
More filters
Journal ArticleDOI

Pathways of empowerment perceptions, health literacy, self-efficacy, and self-care behaviors to glycemic control in patients with type 2 diabetes mellitus.

TL;DR: A hypothesized model exploring the influencing pathways of empowerment perceptions, health literacy, self-efficacy, and self-care behaviors to glycosylated hemoglobin (HbA1c) levels in patients with type 2 diabetes was validated.
Journal ArticleDOI

The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients

TL;DR: There was an increased incidence of cancer at any site in the diabetic patients compared with nondiabetic subjects; and except for breast cancer, their incidences increased independently of hypertension, dyslipidemia, and gout in patients with diabetes.
Journal ArticleDOI

Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan

TL;DR: An increased risk for dementia was identified among the Asian PPI users, and cumulative PPI use was significantly associated with dementia.
Journal ArticleDOI

Diabetes-related kidney, eye, and foot disease in Taiwan: an analysis of the nationwide data for 2000-2009.

TL;DR: In this paper, the prevalence of diabetic nephropathy increased from 13.32% in 2000 to 15.42% in 2009 and the corresponding diabetes dialysis rate increased from 1.5% to 2.46% during the same period (p < 0.001).
Journal ArticleDOI

Blockade of the Renin-Angiotensin System Ameliorates Apelin Production in 3T3-L1 Adipocytes

TL;DR: This study suggests that RAS blockers achieve their beneficial effects by their enhancement of adipocyte secretion of apelin, and this increase was further augmented by blocking RAS.